Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 41.21 billion as of February 5, 2025. Its market cap has decreased by -13.01% in one year.

Market Cap

41.21B

Enterprise Value

45.09B

Revenue

11.80B

Ranking

n/a

PE Ratio

23.75

Stock Price

25.21

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 41.21B, an increase of 469.23%. That is a compound annual growth rate of 33.45%.

Market Cap History

Date	Market Cap	% Change
Feb 5, 2025	41.19B	-1.56%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	94.29B	140.25%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	283.91B
Shenzhen Mindray Bio-Medical Electronics	281.06B
WuXi AppTec	158.63B
Zhangzhou Pientzehuang Pharmaceutical.,	122.18B
Aier Eye Hospital Group	114.63B
Yunnan Baiyao Group Co.,Ltd	103.34B
Shanghai United Imaging Healthcare	101.87B
Beijing Wantai Biological Pharmacy Enterprise	86.14B

Market Cap Rankings